000 01527 a2200373 4500
005 20250511202144.0
264 0 _c19920630
008 199206s 0 0 eng d
022 _a0091-3057
024 7 _a10.1016/0091-3057(91)90106-c
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aJohnson, M P
245 0 0 _aSerotonin neurotoxicity in rats after combined treatment with a dopaminergic agent followed by a nonneurotoxic 3,4-methylenedioxymethamphetamine (MDMA) analogue.
_h[electronic resource]
260 _bPharmacology, biochemistry, and behavior
_cDec 1991
300 _a915-22 p.
_bdigital
500 _aPublication Type: Journal Article; Research Support, U.S. Gov't, P.H.S.
650 0 4 _a3,4-Dihydroxyphenylacetic Acid
_xmetabolism
650 0 4 _a3,4-Methylenedioxyamphetamine
_xadministration & dosage
650 0 4 _aAmphetamine
_xadministration & dosage
650 0 4 _aAnimals
650 0 4 _aBrain
_xdrug effects
650 0 4 _aDopamine
_xmetabolism
650 0 4 _aDopamine Agents
_xadministration & dosage
650 0 4 _aHomovanillic Acid
_xmetabolism
650 0 4 _aHydroxyindoleacetic Acid
_xmetabolism
650 0 4 _aIndans
_xadministration & dosage
650 0 4 _aN-Methyl-3,4-methylenedioxyamphetamine
650 0 4 _aRats
650 0 4 _aSerotonin
_xmetabolism
700 1 _aHuang, X M
700 1 _aNichols, D E
773 0 _tPharmacology, biochemistry, and behavior
_gvol. 40
_gno. 4
_gp. 915-22
856 4 0 _uhttps://doi.org/10.1016/0091-3057(91)90106-c
_zAvailable from publisher's website
999 _c1732587
_d1732587